An International, Multicenter Study to Investigate and Validate Microbiome Configurations and Effectors in CD19-Targeted CAR T Cell Efficacy and Toxicity 2022 Endeavor Award German Cancer Research Center (DKFZ): Eran Elinav, MD, PhD; Cristoph Stein-Thoeringer, MD; • H. Lee Moffitt Cancer Center and Research Institute: Michael Jain, MD, PhD; Marco Davila, MD, PhD • The University of Texas MD Anderson Cancer Center: Robert Jenq, MD Read More
Discovery of Microproteins in Melanoma 2022 Emerging Leader Award Sarah Slavoff, PhD, Yale University Read More
Reprogramming B Cell Fate and Function in Cancer 2022 Emerging Leader Award Yuliya Pylayeva-Gupta, PhD, University Of North Carolina At Chapel Hill Read More
Towards an “Earliest Detection” Assay for Early-Onset Colorectal Cancer 2022 Emerging Leader Award Kamila Naxerova, PhD, Harvard Medical School Read More
Deciphering the Fitness Determinants of Clonal Mosaicism 2022 Emerging Leader Award Dan Landau, MD, PhD, Weill Medical College of Cornell University Read More
Investigating How T Cell Immunosurveillance Restricts Progression of Developing Tumors 2022 Emerging Leader Award Nikhil Joshi, PhD, Yale University Read More
